Literature DB >> 12641428

Synthesis and characterization of N-demethylated metabolites of malachite green and leucomalachite green.

Bongsup P Cho1, Tianle Yang, Lonnie R Blankenship, Joanna D Moody, Mona Churchwell, Frederick A Beland, Sandra J Culp.   

Abstract

Malachite green (MG), a triphenylmethane dye used to treat fungal and protozoan infections in fish, undergoes sequential oxidation to produce various N-demethylated derivatives (monodes-, dides(sym)-, dides(unsym)-, trides-, and tetrades-) both before and after reduction to leucomalachite green (LMG). The close structure resemblance of the metabolites with aromatic amine carcinogens implicates a potential genotoxicity from exposure to MG. The availability of the synthetic standards is important for metabolic and DNA adduct studies of MG. This paper describes a simple and versatile method for the synthesis of MG, LMG, and their N-demethylated metabolites. The synthesis involves a coupling of 4-(dimethylamino)benzophenone or 4-nitrobenzophenone with the aryllithium reagents derived from appropriately substituted 4-bromoaniline derivatives, followed by treatment with HCl in methanol. The resulting cationic MG and their leuco analogues showed systematic UV/vis spectral and tandem mass fragmentation patterns consistent with sequential N-demethylation. The extensive (1)H and (13)C spectral assignments of the metabolites were aided by the availability of (13)C(7)-labeled MG and LMG. The results indicate the existence of a resonance structure with the cationic charge located in the central methane carbon (C(7)). The synthetic procedure is general in scope so that it can be extended to the preparation of N-demethylated metabolites of other structurally related N-methylated triphenylmethane dyes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12641428     DOI: 10.1021/tx0256679

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  8 in total

1.  Using C. elegans for antimicrobial drug discovery.

Authors:  Athanasios Desalermos; Maged Muhammed; Justin Glavis-Bloom; Eleftherios Mylonakis
Journal:  Expert Opin Drug Discov       Date:  2011-06-01       Impact factor: 6.098

2.  SbCl(3)-catalyzed one-pot synthesis of 4,4'-diaminotriarylmethanes under solvent-free conditions: Synthesis, characterization, and DFT studies.

Authors:  Ghasem Rezanejade Bardajee
Journal:  Beilstein J Org Chem       Date:  2011-01-31       Impact factor: 2.883

3.  Kinetic study of gold nanoparticle mediated photocatalytic degradation of Victoria blue.

Authors:  P Jishma; Thomas Roshmi; S Snigdha; E K Radhakrishnan
Journal:  3 Biotech       Date:  2018-01-25       Impact factor: 2.406

Review 4.  Caenorhabditis elegans-based model systems for antifungal drug discovery.

Authors:  Cleo G Anastassopoulou; Beth Burgwyn Fuchs; Eleftherios Mylonakis
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

5.  Determining the degradation efficiency and mechanisms of ethyl violet using HPLC-PDA-ESI-MS and GC-MS.

Authors:  Wen-Hsin Chung; Chung-Shin Lu; Wan-Yu Lin; Jian-Xun Wang; Chia-Wei Wu; Chiing-Chang Chen
Journal:  Chem Cent J       Date:  2012-06-30       Impact factor: 4.215

6.  Immobilized Cerrena sp. laccase: preparation, thermal inactivation, and operational stability in malachite green decolorization.

Authors:  Jie Yang; Zhengjuan Wang; Yonghui Lin; Tzi Bun Ng; Xiuyun Ye; Juan Lin
Journal:  Sci Rep       Date:  2017-11-27       Impact factor: 4.379

7.  Kinetics and thermodynamics of hydrolysis of crystal violet at ambient and below ambient temperatures.

Authors:  Nurudeen Salahudeen; Adamu A Rasheed
Journal:  Sci Rep       Date:  2020-12-14       Impact factor: 4.379

8.  Identification of antifungal compounds active against Candida albicans using an improved high-throughput Caenorhabditis elegans assay.

Authors:  Ikechukwu Okoli; Jeffrey J Coleman; Emmanouil Tampakakis; Emmanouil Tempakakis; W Frank An; Edward Holson; Florence Wagner; Annie L Conery; Jonah Larkins-Ford; Gang Wu; Andy Stern; Frederick M Ausubel; Eleftherios Mylonakis
Journal:  PLoS One       Date:  2009-09-14       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.